| scholarly article | Q13442814 |
| P2093 | author name string | M B Oldstone | |
| P L Schwimmbeck | |||
| D T Yu | |||
| P2860 | cites work | A simple method for displaying the hydropathic character of a protein | Q26778481 |
| Complete sequence of HLA-B27 cDNA identified through the characterization of structural markers unique to the HLA-A, -B, and -C allelic series | Q28116387 | ||
| Serologic relatedness between Thy-1.2 and actin revealed by monoclonal antibody | Q28261229 | ||
| The structure of an antigenic determinant in a protein | Q29547829 | ||
| Sequential studies in ankylosing spondylitis. Association of Klebsiella pneumoniae with active disease | Q33554375 | ||
| Discordance for ankylosing spondylitis in monozygotic twins | Q33570100 | ||
| Ankylosing spondylitis, HLA-B27 and Klebsiella. I. Cross-reactivity studies with rabbit antisera. | Q36091349 | ||
| Possible role for a human adenovirus in the pathogenesis of celiac disease | Q36349555 | ||
| Comparison of the iron proteins from the nitrogen fixation complexes of Azotobacter vinelandii, Clostridium pasteurianum, and Klebsiella pneumoniae | Q36396192 | ||
| Peptides as probes to study molecular mimicry and virus-induced autoimmunity | Q39748455 | ||
| Solid-phase peptide synthesis | Q39891195 | ||
| Epitopes of streptococcal M proteins shared with cardiac myosin | Q40816419 | ||
| Amino acid homology between the encephalitogenic site of myelin basic protein and virus: mechanism for autoimmunity | Q44765063 | ||
| Myosin: a link between streptococci and heart | Q45060165 | ||
| High Association of an HL-A Antigen, W27, with Ankylosing Spondylitis | Q48012715 | ||
| Nucleotide sequence of the gene coding for the nitrogenase iron protein from Klebsiella pneumoniae | Q48410261 | ||
| One allogeneic cytolytic T lymphocyte clone distinguishes three different HLA-B27 subtypes: identification of amino acid residues influencing the specificity and avidity of recognition | Q68943177 | ||
| HLA-B27 antigenicity: antibodies against the chemically synthesized 63-84 peptide from HLA-B27.1 display alloantigenic specificity and discriminate among HLA-B27 subtypes | Q68966248 | ||
| Antiserum to Klebsiella K43 BTS 1 specifically lyses lymphocytes of HLA-B27-positive patients with ankylosing spondylitis from a London population | Q69856708 | ||
| Iga Antibodies to Klebsiella Pneumoniae in Ankylosing Spondylitis | Q70286037 | ||
| Mimicking the alloantigenicity of proteins with chemically synthesized peptides differing in single amino acids | Q71151401 | ||
| Serotyping for homotransplantation. 18. Refinement of microdroplet lymphocyte cytotoxicity test | Q72147700 | ||
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | ankylosing spondylitis | Q52849 |
| Klebsiella pneumoniae | Q132592 | ||
| patient | Q181600 | ||
| autoantibody | Q785022 | ||
| P304 | page(s) | 173-181 | |
| P577 | publication date | 1987-07-01 | |
| P1433 | published in | Journal of Experimental Medicine | Q3186912 |
| P1476 | title | Autoantibodies to HLA B27 in the sera of HLA B27 patients with ankylosing spondylitis and Reiter's syndrome. Molecular mimicry with Klebsiella pneumoniae as potential mechanism of autoimmune disease | |
| P478 | volume | 166 |
| Q33265731 | A Ribosomal Protein ofYersina PseudotuberculosisHaving Partial Epitope Identity with HLA-B27 |
| Q45123730 | A distinctive cutaneous reaction pattern indicative of infection by reactive arthropathy-associated microbial pathogens: the superantigen ID reaction |
| Q36586989 | A hypothesis for the HLA-B27 immune dysregulation in spondyloarthropathy: contributions from enteric organisms, B27 structure, peptides bound by B27, and convergent evolution |
| Q35555732 | A longitudinal study on an autoimmune murine model of ankylosing spondylitis |
| Q36581505 | A possible link between Crohn's disease and ankylosing spondylitis via Klebsiella infections |
| Q33564737 | Absence of autoantibodies to peptides shared by HLA-B27.5 and Klebsiella pneumoniae nitrogenase in serum samples from HLA-B27 positive patients with ankylosing spondylitis and Reiter's syndrome |
| Q24817182 | Aetiology and pathogenesis of reactive arthritis: role of non-antigen-presenting effects of HLA-B27 |
| Q40493543 | Allele-dependent similarity between viral and self-peptide presentation by HLA-B27 subtypes |
| Q77803177 | Animal models of human leukocyte antigen B27-linked arthritides |
| Q34594071 | Ankylosing spondylitis is linked to Klebsiella--the evidence |
| Q33564014 | Ankylosing spondylitis: an autoimmune disease? |
| Q41510579 | Antibodies to the peptide from the plasmid-coded Yersinia outer membrane protein (YOP1) in patients with ankylosing spondylitis |
| Q42937717 | Antibody activity in ankylosing spondylitis sera to two sites on HLA B27.1 at the MHC groove region (within sequence 65-85), and to a Klebsiella pneumoniae nitrogenase reductase peptide (within sequence 181-199). |
| Q33564359 | Antibody to a 63 kilodalton insect protein in ankylosing spondylitis |
| Q36635307 | Antigen Recognition and Peptide-Mediated Immunotherapy in Autoimmune Disease |
| Q36706366 | Antigenic Mimicry and Autoimmune Diseases |
| Q37959181 | Are the inflammatory bowel diseases autoimmune disorders? |
| Q24680278 | Autoantibodies from patients with primary biliary cirrhosis recognize a restricted region within the cytoplasmic tail of nuclear pore membrane glycoprotein Gp210 |
| Q34261751 | Autoantibodies to the HLA-B27 sequence cross-react with the hypothetical peptide from the arthritis-associated Shigella plasmid. |
| Q35791661 | Autoimmunity in Rheumatic Diseases Is Induced by Microbial Infections via Crossreactivity or Molecular Mimicry |
| Q37727845 | Autoimmunity in periodontal disease |
| Q40387286 | Autoimmunity-prone B-1 (CD5 B) cells, natural antibodies and self recognition |
| Q46970314 | B27 disease is a new autoimmune disease that affects millions of people |
| Q40396703 | Bacteria-specific cytotoxic CD8+ T cells: a missing link in the pathogenesis of the HLA-B27-associated spondylarthropathies |
| Q34640695 | Bovine spongiform encephalopathy: is it an autoimmune disease due to bacteria showing molecular mimicry with brain antigens? |
| Q33829471 | Chimeric cytotoxin IL2-PE40 delays and mitigates adjuvant-induced arthritis in rats. |
| Q35229830 | Clinical, bacteriological, and serological aspects of Klebsiella infections and their spondylarthropathic sequelae |
| Q69558046 | Complexes of soluble HLA antigens and anti-HLA autoantibodies in human sera: possible role in maintenance of self-tolerance |
| Q40362650 | Conformational dimorphism of self-peptides and molecular mimicry in a disease-associated HLA-B27 subtype |
| Q36633507 | Contemporary issues: diseases with a food vector |
| Q42695100 | Cross-reactivity between an HLA-B27-derived peptide and a retinal autoantigen peptide: a clue to major histocompatibility complex association with autoimmune disease |
| Q41233113 | Differences in HLA-B27 positive and negative patients with ankylosing spondylitis: study of clinical disease activity and concentrations of serum IgA, C reactive protein, and haptoglobin |
| Q37804351 | Enhanced inflammatory reactivity in the pathogenesis of spondyloarthropathies. |
| Q67672055 | Epitope mapping of an HLA-B27 monoclonal antibody that also reacts with a 35-kD bacterial outer-membrane protein |
| Q35549224 | Evidence of genetic susceptibility to Chlamydia trachomatis-induced pelvic inflammatory disease in the pig-tailed macaque. |
| Q91935600 | Examining pathogenic concepts of autoimmune hepatitis for cues to future investigations and interventions |
| Q41298933 | Experimental autoimmune uveitis: molecular mimicry and oral tolerance |
| Q50273061 | Expression of activation-induced cytidine deaminase splicing variants in patients with ankylosing spondylitis. |
| Q67677375 | Failure to Detect Cross-reacting Antibodies to HLA-B27.5 andKlebsiella pneumoniaeNitrogenase in Sera from Patients with Ankylosing Spondylitis and Reiter's Syndrome |
| Q37948067 | Genetic approaches in the study of periodontal diseases |
| Q38198496 | Genetics of the spondarthropathies |
| Q37946777 | HLA-B27 and acute anterior uveitis |
| Q41134948 | HLA-B27 and bacteria |
| Q27313830 | HLA-B27 and human β2-microglobulin affect the gut microbiota of transgenic rats |
| Q33734659 | HLA-B27 associated spondyloarthropathy, an autoimmune disease based on crossreactivity between bacteria and HLA-B27? |
| Q45227943 | HLA-B27 binding of peptide from its own sequence and similar peptides from bacteria: implications for spondyloarthropathies |
| Q49084368 | HLA-B27 positive ankylosing spondylitis and polyarteritis nodosa: a case report |
| Q70549043 | HLA-B27 subtypes in the spondarthropathies |
| Q35448556 | HLA-B27 subtypes: implications for the spondyloarthropathies |
| Q41105561 | HLA-B27/microbial mimicry: an in vivo analysis |
| Q41577346 | HLA-B∗0702 antibody epitopes are affected indirectly by distant antigen residues |
| Q35182310 | Hla and disease |
| Q68548833 | How does HLA-B27 confer susceptibility to inflammatory arthritis? |
| Q37542520 | Immune functions and inflammatory reactions in HLA-B27 positive subjects |
| Q56900044 | Immune response genes in uveitis |
| Q40414742 | Immunology of Theiler's murine encephalomyelitis virus infection |
| Q77463928 | Induction of arthritis and uveitis in Lewis rats by antigenic mimicry of peptides from HLA-B27 and cytokeratin |
| Q34474693 | Inflammatory bowel disease and spondylarthropathy |
| Q40317422 | Inhibition of Klebsiella pneumoniae growth by selected Australian plants: natural approaches for the prevention and management of ankylosing spondylitis |
| Q38749323 | Intestinal permeability, non-steroidal anti-inflammatory drug enteropathy and inflammatory bowel disease: an overview |
| Q36654712 | Investigation of Cardiac Complications and their Incidence in Patients with Ankylosing Spondylitis |
| Q68425614 | Involvement of major histocompatibility complex class I antigens in T cell activation |
| Q38718467 | Leukocyte-endothelial cell interaction and the control of leukocyte migration into inflamed synovium |
| Q37953424 | Lymphocyte homing into the gut. |
| Q41507719 | Molecular mimickry between HLA B27 and Yersinia, Salmonella, Shigella and Klebsiella within the same region of HLA α1-helix |
| Q71994652 | Molecular mimicry and ankylosing spondylitis: possible role of a novel sequence in pullulanase of Klebsiella pneumoniae |
| Q35333128 | Molecular mimicry and autoantigens in connective tissue diseases |
| Q34474075 | Molecular mimicry and immune-mediated diseases |
| Q24621002 | Molecular mimicry and myasthenia gravis. An autoantigenic site of the acetylcholine receptor alpha-subunit that has biologic activity and reacts immunochemically with herpes simplex virus |
| Q38610595 | Molecular mimicry as a mechanism for virus-induced autoimmunity |
| Q37957762 | Molecular mimicry as a mechanism of autoimmune disease |
| Q34094883 | Molecular mimicry between HLA-DR alleles associated with rheumatoid arthritis and Proteus mirabilis as the Aetiological basis for autoimmunity |
| Q44368606 | Molecular mimicry, ankylosing spondylitis and reactive arthritis--something missing? |
| Q36331625 | Molecular mimicry, microbial infection, and autoimmune disease: evolution of the concept. |
| Q33581522 | Molecular mimicry--hypothesis or reality? |
| Q40641469 | Molecular mimicry. |
| Q40384526 | Molecular mimicry: any role in the pathogenesis of spondyloarthropathies? |
| Q40884772 | Molecular mimicry: its evolution from concept to mechanism as a cause of autoimmune diseases |
| Q40957878 | Molecular mimicry: the geographical distribution of immune responses to Klebsiella in ankylosing spondylitis and its relevance to therapy |
| Q37552271 | Multiple overlapping homologies between two rheumatoid antigens and immunosuppressive viruses |
| Q41602436 | Mutagenesis around residue 176 on HLA-B∗0702 characterizes multiple distinct epitopes for anti-HLA antibodies |
| Q42702219 | No human protein is exempt from bacterial motifs, not even one. |
| Q90103700 | PROBIOTICS - A PROBABLE THERAPEUTIC AGENT FOR SPONDYLOARTHROPATHY |
| Q38014963 | Peptides: chemistry, biology, and pharmacology |
| Q33560902 | Polymorphonuclear leucocyte function and previous yersinia arthritis: correlation of enhanced superoxide production with late manifestations |
| Q41349761 | Presentation of HLA class I-derived peptides: potential involvement in allorecognition and HLA-B27-associated arthritis |
| Q41516961 | Production of tumour necrosis factor and interleukin 1 by monocytes of patients with previous Yersinia arthritis. |
| Q40626780 | Proinflammatory responses to self HLA epitopes are triggered by molecular mimicry to Epstein-Barr virus proteins in oligoarticular juvenile idiopathic arthritis. |
| Q54750287 | Prospective Analysis of 16S rDNA as a Highly Sensitive Marker for Bacterial Presence in Peyronie’s Disease Plaques |
| Q58110747 | RELATIONSHIP BETWEEN FOODBORNE BACTERIAL PATHOGENS AND THE REACTIVE ARTHRITIDES |
| Q38266805 | Raised incidence of ankylosing spondylitis among Inuit populations could be due to high HLA-B27 association and starch consumption |
| Q35084874 | Reactive arthritis: newer developments |
| Q38752559 | Reactivity between monoclonal anti-HLA-B27 antibodies and bacterial components: is there a consensus of findings? |
| Q35108067 | Recognition of binding sites on Candida albicans by monoclonal antibodies to human leukocyte antigens |
| Q41757848 | Reiter's syndrome among Asian shipboard immigrants: the case of The Golden Venture. |
| Q45274911 | Relating homology between the Epstein-Barr virus BOLF1 molecule and HLA-DQw8 beta chain to recent onset type 1 (insulin-dependent) diabetes mellitus |
| Q41486201 | Relationship between HLA antigens and infectious agents in contributing towards the development of Graves' disease. |
| Q33710857 | Rheumatic disease and cystic fibrosis |
| Q77803126 | Rheumatologic manifestations of gastrointestinal diseases |
| Q35532723 | Role of class I molecules of the major histocompatibility complex in cytotoxic T-cell function in health and disease |
| Q41671690 | Role of endogenous enteric organisms in the reactivation of arthritis |
| Q41492327 | Serum antibodies from patients with ankylosing spondylitis and Reiter's syndrome are reactive with HLA-B27 cells transfected with the Mycobacterium tuberculosis hsp60 gene |
| Q27008648 | Slipping through the Cracks: Linking Low Immune Function and Intestinal Bacterial Imbalance to the Etiology of Rheumatoid Arthritis |
| Q41010902 | Spondylarthropathies: from gut to target organs |
| Q42644703 | Studies of humoral and cell-mediated immunity to peptides shared by HLA-27.1 and Klebsiella pneumoniae nitrogenase in ankylosing spondylitis |
| Q36707517 | Systemic lupus erythematosus: RNA-protein autoantigens, models of disease heterogeneity, and theories of etiology |
| Q40541780 | T-cell antigen receptors in rheumatoid arthritis |
| Q67673689 | The Use of Enzyme Immunoassay (EIA) and Radiobinding Assay to Investigate the Cross-reactivity of Klebsiella Antigens and HLAB27 in Ankylosing Spondylitis Patients and Healthy Controls |
| Q44416332 | The arthritogenic properties of microbial antigens. Their implications in disease states |
| Q36236745 | The genetics of human autoimmune disease: A perspective on progress in the field and future directions |
| Q77936247 | The immunogenetics of the seronegative spondyloarthropathies |
| Q36918422 | The link between ankylosing spondylitis, Crohn's disease, Klebsiella, and starch consumption |
| Q36519669 | The microbiome, autoimmunity, and arthritis: cause and effect: an historical perspective. |
| Q46811981 | The potential of selected South African plants with anti-Klebsiella activity for the treatment and prevention of ankylosing spondylitis |
| Q37260906 | The role of Klebsiella in Crohn's disease with a potential for the use of antimicrobial measures |
| Q37900726 | The role of infectious agents in the spondylarthropathies |
| Q28284835 | The role of the microbiome in rheumatic diseases |
| Q35596846 | The susceptibility sequence to rheumatoid arthritis is a cross-reactive B cell epitope shared by the Escherichia coli heat shock protein dnaJ and the histocompatibility leukocyte antigen DRB10401 molecule |
| Q34400086 | The use of a low starch diet in the treatment of patients suffering from ankylosing spondylitis |
| Q46441895 | Tolerance to a self peptide from the third hypervariable region of the Es beta chain. Implications for molecular mimicry models of autoimmune disease |
| Q33565028 | Ulcerative colitis complicating seronegative HLA-A2-B27 rheumatoid arthritis with sacroiliitis |
| Q41225504 | Using transgenic mouse models to dissect the pathogenesis of virus-induced autoimmune disorders of the islets of Langerhans and the central nervous system |
| Q38050863 | Viral infections and molecular mimicry in type 1 diabetes |
| Q38687433 | Virus-induced autoimmunity: molecular mimicry as a route to autoimmune disease |
Search more.